To conclude, in our cohort of 867 Northern European type 1 diabetes patients, the previously described -945GC SNP appears not to have a major impact on plasma CTGF levels, incidence and prognosis of nephropathy, and cardiovascular outcome. Here, CCN2 is linked to type 1 diabetes mellitus.